Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

News > All

Total search results: 9799 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 42 43 44 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Formycon AG. (4/16/15). "Press Release: Formycon AG Successfully Completes Capital Increase from Approved Capital". Munich. 2015-04-16
Omeicos Therapeutics GmbH. (4/15/15). "Press Release: Omeicos Therapeutics Raises EUR 6.2 Million in Series A to Advance Lead Candidate in Atrial Fibrillation". Berlin. 2015-04-15
Sophia Genetics S.A.. (4/15/15). "Press Release: Sophia Genetics’ Technology to Be Used by University Hospitals in Cologne and Düsseldorf to Improve Diagnosis of Hereditary Breast and Ovarian Cancer Patients". Lausanne. 2015-04-15
NanoTemper Technologies GmbH. (4/15/15). "Press Release: NanoTemper Technologies Inaugurates New Subsidiaries in Cambridge, UK and Krakow, Poland". 2015-04-15
MC Services AG. (4/14/15). "Press Release: MC Services Further Expands Its Financial Communications Expertise with the Appointment of Fabian Lorenz as a Senior Consultant". Düsseldorf. 2015-04-14
4SC AG. (4/14/15). "Press Release: 4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding Japan". Planegg-Martinsried & Singapore. 2015-04-14
Boehringer Ingelheim. (4/13/15). "Press Release: Hydra Biosciences and Boehringer Ingelheim Enter Research Collaboration Focused on Renal Diseases and Disorders". Cambridge, MA & Ingelheim. 2015-04-13
Roche. (4/13/15). "Press Release: Roche Strengthens Oncology Translational Research Pipeline by Acquiring CAPP Medical". Pleasanton, CA. 2015-04-13
Accovion GmbH. (4/13/15). "Press Release: Accovion Signs Agreement to Be Acquired by Clinipace Worldwide". Frankfurt & Eschborn. 2015-04-13
MorphoSys AG. (4/13/15). "Press Release: MorphoSys to Receive Milestone Payment for Guselkumab Program in Psoriatic Arthritis". 2015-04-13
Merck KGaA. (4/13/15). "Press Release: Merck Appoints Udit Batra to Head Combined Life Science Business Following Pending Sigma-Aldrich Acquisition". Darmstadt. 2015-04-13
Santhera Pharmaceuticals. (4/9/15). "Press Release: Santhera Receives FDA Fast Track Designation for Raxone/Catena (idebenone) for theTreatment of Duchenne Muscular Dystrophy". Liestal. 2015-04-09
MorphoSys AG. (4/8/15). "Press Release: MorphoSys to Start Share Buy-Back Program". 2015-04-08
Roche. (4/8/15). "Press Release: EU Approves Roche's Avastin plus Chemotherapy for Women with Advanced Cervical Cancer". Basel. 2015-04-08
Biofrontera AG. (4/8/15). "Press Release: Biofrontera Stabilizes Shareholder Structure. Block Trade Completed Off-market – Biofrontera Enters Essential Growth Phase with Long-term Investors". Leverkusen. 2015-04-08
Prothena Corporation plc. (4/8/15). "Press Release: Prothena Announces Pricing of Public Offering of 3,300,000 Ordinary Shares". Dublin. 2015-04-08
Wilex AG. (4/8/15). "Press Release: Wilex AG Successfully Completes Rights Issue". Munich. 2015-04-08
Ipsen S.A.. (4/8/15). "Press Release: Ipsen and Hannover Medical School Start Joint Research in Recombinant Botulinum Neurotoxins for Targeted Secretion Inhibitors. Key Steps in Thirty Months Research Program Underway". Paris & Hannover. 2015-04-08
Blueberry Therapeutics Ltd.. (4/8/15). "Press Release: Blueberry Raises $1.75M in Investment". 2015-04-08
Indivumed GmbH. (4/7/15). "Press Release: William R. Gruver Agrees to Lead Indivumed Business Advisory Team". Hamburg. 2015-04-07
Nabriva Therapeutics AG. (4/7/15). "Press Release: Nabriva Therapeutics Announces Financing of up to $120M to Advance Clinical Development of New Class of Antibiotic". Vienna & Philadelphia, PA. 2015-04-07
Roche. (4/7/15). "Press Release: Roche Announces Preliminary Results of Tender Offer for Foundation Medicine, Inc.". Basel. 2015-04-07
CRISPR Therapeutics AG. (4/7/15). "Press Release: CRISPR Therapeutics to Establish R&D Operations in Cambridge, Massachusetts. Company Appoints Bill Lundberg, M.D., as Chief Scientific Officer". Basel & Cambridge, MA. 2015-04-07
Merck KGaA. (4/7/15). "Press Release: Global Strategic Partners Merck and Pfizer Finalize Agreement to Co-Promote Xalkori (crizotinib)". Darmstadt & New York. 2015-04-07
Sophia Genetics S.A.. (4/7/15). "Press Release: Sophia Genetics Expands in Germany and Austria with Significant New Clients in Karlsruhe, Mannheim and Vienna". Lausanne. 2015-04-07
Bruker Corporation. (4/3/15). "Press Release: Bruker Announces FDA Clearance for Second, Expanded Claim for the MALDI Biotyper CA System". Billerica, MA. 2015-04-03
GlaxoSmithKline plc. (4/2/15). "Press Release: GSK to Establish Global Vaccines R&D Centre in the US. New Hub Based in Rockville, MD Expands GSK’s Global Vaccines R&D Footprint". London & Philadelphia, PA. 2015-04-02
Qiagen N.V.. (4/2/15). "Press Release: Qiagen Announces Proposal for Re-election of All Current Supervisory Board Members at Next Annual General Meeting". Venlo. 2015-04-02
AMP Biosimilars AG. (4/2/15). "Corporate Presentation [April 2015]". Hamburg. 2015-04-02
PeptiDream Inc.. (4/2/15). "Press Release: PeptiDream Announces License of PeptiDream’s Peptide Discovery Platform System (PDPS) Technology to Novartis". Tokyo. 2015-04-02
AMP Biosimilars AG. (4/2/15). "Press Release: AMP Biosimilars AG – Second German “Pure Play” Biosimilars Listing. Successful Trading Launch on the Munich Stock Exchange". Hamburg. 2015-04-02
Caribou Biosciences, Inc.. (4/2/15). "Press Release: Caribou Biosciences Raises $11 Million in Series A Funding". 2015-04-02
InflaRx GmbH. (4/15). "Press Release: InflaRx Receives Large Scale Government Grant from BMBF". 2015-04-01
Basilea Pharmaceutica Ltd.. (4/1/15). "Press Release: Basilea In-licenses Targeted Cancer Therapy". Basel. 2015-04-01
4SC AG. (4/1/15). "Press Release: Dr Susanne Danhauser-Riedl Joins 4SC as Chief Medical Officer to Strengthen Management and Clinical Development Team". Planegg-Martinsried. 2015-04-01
Merck KGaA. (4/1/15). "Press Release: Merck Serono and Medicines for Malaria Venture Sign Agreement to Develop Potential Antimalarial Therapy". Darmstadt. 2015-04-01
Bayer AG. (4/1/15). "Press Release: New Phase 3 Study in China Confirms Vision Improvement for Patients with Wet Age-Related Macular Degeneration when Receiving Aflibercept Solution for Intravitreal Injection [Not intended for U.S. and UK Media ]". Berli 2015-04-01
Lead Discovery Center GmbH. (3/31/15). "Press Release: LDC and HZI Enter Partnership for the Discovery of New Drugs against Multi-resistant Bacteria". Dortmund. 2015-03-31
Bayer AG. (3/31/15). "Press Release: Personalized Cardiology. Bayer HealthCare Expands Collaboration with Broad Institute of MIT and Harvard to Develop Therapies for Cardiovascular Disease [Not intended for UK Media]". Leverkusen. 2015-03-31
Evolva Holding S.A.. (3/31/15). "Press Release: Evolva Publishes Financial Results for 2014". 2015-03-31
Direvo Industrial Biotechnology GmbH. (3/31/15). "Press Release: Direvo Announces the USPTO Issuance of a Patent Claiming the Use of Enzyme Mixes In Biorefineries". Cologne. 2015-03-31
Greenovation Biotech GmbH. (3/31/15). "Press Release: Greenovation and University of Freiburg Cooperate to Fight an Extremely Rare Disease". Freiburg. 2015-03-31
High-Tech Gründerfonds Management GmbH. (3/31/15). "Press Release: A Consortium Led by High-Tech Gründerfonds and Innovationsstarter Invests in Sonormed. E-health Solution Tinnitracks Can Alleviate Tinnitus". 2015-03-31
Merck KGaA. (3/30/15). "Press Release: Merck Serono and Intrexon Announce Agreement for the Development and Commercialization of CAR-T Therapy". Darmstadt. 2015-03-30
Novartis AG. (3/30/15). "Press Release: Novartis Accelerates Cancer Immunotherapy Efforts with Aduro Biotech Alliance and Launch of New Immuno-oncology Research Group". Basel. 2015-03-30
Pieris Pharmaceuticals, Inc.. (3/30/15). "Press Release: Pieris Pharmaceuticals and the University of Melbourne Receive Research Grant to Advance Immunological Diseases Program". Freising & Melbourne. 2015-03-30
MorphoSys AG. (3/30/15). "Press Release: MorphoSys Nominates Three New Candidates for Supervisory Board". 2015-03-30
Novartis AG. (3/30/15). "Press Release: Novartis Announces FDA Approval for Jadenu to Simplify Treatment Administration for Patients with Chronic Iron Overload". Basel. 2015-03-30
Bayer AG. (3/30/15). "Press Release: Bayer Issues EUR 1.3 Billion in Hybrid Capital". Leverkusen. 2015-03-30
BioMed X GmbH. (3/30/15). "Press Release: AbbVie and BioMed X Collaborate to Develop Novel Approaches for the Treatment of Alzheimer's Disease". Heidelberg. 2015-03-30
Biocartis N.V.. (3/26/15). "Press Release: Biocartis and Microbiome Sign Collaboration to Develop Rapid and Sensitive Sepsis Test". Mechelen & Amsterdam. 2015-03-26
MorphoSys AG. (3/26/15). "Press Release: MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration. MorphoSys Regains Rights to MOR202 Antibody Against CD38 and Updates Its Financial Guidance for 2015". 2015-03-26
Evotec AG. (3/26/15). "Press Release: Asahi Kasei Pharma Selects Evotec as Its Partner for Ion Channel Drug Discovery". Hamburg. 2015-03-26
Bayer AG. (3/26/15). "Press Release: Bayer Receives Approval for Gadovist (gadobutrol) Injection in Japan [Not intended for U.S. and UK Media]". Leverkusen. 2015-03-26
Valneva S.E.. (3/26/15). "Press Release: Valneva Announces Approval of an EB66-based Prototype Influenza Vaccine in Japan". Lyon. 2015-03-26
Apceth GmbH & Co. KG. (3/26/15). "Press Release: Apceth Initiates Phase II Clinical Trial for Pioneering Engineered Cell Therapy to Treat Gastrointestinal Cancer". Munich. 2015-03-26
Wilex AG. (3/26/15). "Press Release: Wilex Announces Financial Figures for the 2014 Financial Year and Reports on Course of Business". Munich. 2015-03-26
Evolva Holding S.A.. (3/26/15). "Press Release: Evolva and Valent BioSciences to Co-develop Agricultural Bioactives". 2015-03-26
Analytik Jena AG. (3/26/15). "Press Release: Analytik Jena AG Leaves the Stock Exchange". Jena. 2015-03-26
4SC AG. (3/25/15). "Press Release: 4SC Publishes Results for Financial Year 2014". Planegg-Martinsried. 2015-03-25
Pieris Pharmaceuticals, Inc.. (3/25/15). "Press Release: Pieris Pharmaceuticals Reports Full-Year 2014 Financial Results and Provides Corporate Update". Freising. 2015-03-25
Biofrontera AG. (3/25/15). "Press Release: Biofrontera Starts Sales and Marketing of Ameluz in Spain. Key Account Manager Transfers from Allergan to Biofrontera". Leverkusen. 2015-03-25
Mologen AG. (3/25/15). "Press Release: Start of Pivotal Study for Cancer Immunotherapy MGN1703 Influences 2014 Annual Result". 2015-03-25
Epigenomics AG. (3/25/15). "Press Release: Epigenomics Announces Completion of Enrollment in Epi proColon ADMIT Trial". Berlin & Germantown, MD. 2015-03-25
Epigenomics AG. (3/25/15). "Press Release: Epigenomics AG Reports Results for the Financial Year Ended December 31, 2014 and Provides Outlook for 2015". Berlin & Germantown, MD. 2015-03-25
Affimed N.V.. (3/25/15). "Press Release: Affimed Announces Financial Results for Fourth Quarter and Year End 2014". Heidelberg. 2015-03-25
BIA Separations GmbH. (3/25/15). "Press Release: BIA Separations Appoints Hichrom as Distributor". 2015-03-25
Medigene AG. (3/25/15). "Press Release: Medigene Publishes Final Financials 2014. Significant Improvement in Revenue, EBITDA and Net Result". Martinsried. 2015-03-25
Cytos Biotechnology AG. (3/25/15). "Press Release: Novartis Buys Out CAD 106 License Agreement for CHF 4 Million". Schlieren. 2015-03-25
High-Tech Gründerfonds Management GmbH. (3/24/15). "Press Release: Rigontec GmbH Raises €4.8m in a Second Closing of Its Series A Financing. Brings Series A Total to €14.25m to Advance RNA-based Immunotherapeutics for Cancer and Viral Diseases". 2015-03-24
Evotec AG. (3/24/15). "Press Release: Evotec FY 2014 – Strong Performance in EVT Execute and Acceleration of EVT Innovate". Hamburg. 2015-03-24
Medigene AG. (3/24/15). "Press Release: Medigene Starts Phase I/II Study with DC Vaccine to Treat Acute Myeloid Leukaemia (AML)". Martinsried. 2015-03-24
Affimed N.V.. (3/24/15). "Press Release: Affimed Completes TandAb Development Candidate Activities Meeting Amphivena’s and Janssen’s Criteria and Achieves Milestone Ahead of Schedule". Heidelberg. 2015-03-24
JPIF Management B.V.. (3/23/15). "Press Release: Poland’s First Institutional Venture Capital Fund Dedicated to Life Science Announces First Closing At $ 42 Million". Warsaw. 2015-03-23
HalioDx S.A.S.. (3/23/15). "Press Release: Creation of HalioDx. A Management Buy-out by the Qiagen Marseille Executive Team". Marseille. 2015-03-23
BIOPRO Baden-Württemberg GmbH [KS]. (3/23/15). "Press Release: Cytena GmbH Facilitates the Separation of Single Cells". 2015-03-23
Life Science Nord. (3/20/15). "Press Release: The Netherlands in North Germany. Life Science Startups Present Innovative Technologies to Members of the Delegation". Hamburg & Schleswig-Holstein. 2015-03-20
Novartis AG. (3/20/15). "Press Release: New Novartis Data Shows Cosentyx Is Significantly Superior to Stelara and Clears Skin (PASI 90) in Nearly 80% of Psoriasis Patients". Basel. 2015-03-20
Evotec AG. (3/20/15). "Press Release: Evotec and Sanofi Sign Definitive Agreement for Major Multi-component Strategic Alliance. Total Deal Value of EUR 250 m, including more than EUR 40 m Upfront Cash Payment". Hamburg. 2015-03-20
Boehringer Ingelheim. (3/20/15). "Press Release: Boehringer Ingelheim’s Investigational Biologic Cleared Skin Better than Ustekinumab in Head-to-head Phase II Psoriasis Study [For non-UK / non-Canadian media only]". San Francisco, CA & Ingelheim. 2015-03-20
Sygnis AG. (03/18/15). "Press Release: Sygnis Signs Non-exclusive Distribution Agreement with Sopachem for TruePrime Product Family in Belgium". Madrid. 2015-03-19
GATC Biotech AG. (3/19/15). "Press Release: GATC Biotech Becomes First European Services Provider Offering Full Access to Qiagen’s Ingenuity Variant Analysis". Constance. 2015-03-19
Roche. (3/19/15). "Press Release: Roche Announces Global Distribution Agreement for Its Biochemical Reagents Product Portfolio with Sigma-Aldrich". Pleasanton, CA. 2015-03-19
Tecan Group Ltd.. (3/18/15). "Press Release: Tecan with Strong Order Entry and Good Sales Development in the Second Half of 2014. Financial Results – Full-year and Second Half of 2014". Männedorf. 2015-03-18
Tecan Group Ltd.. (3/18/15). "Press Release: Lars Holmqvist to Be Proposed to the Upcoming Annual General Meeting as a New Member of the Board of Tecan". Männedorf. 2015-03-18
Scienion AG. (3/18/15). "Press Release: Scienion US, Inc. Receives ISO 13485 Certification". Monmouth Junction, NJ. 2015-03-18
NEO New Oncology AG. (3/17/15). "Press Release: New Oncology Closes Financing Round to Promote Genetic Testing from Blood". Cologne. 2015-03-17
Merck KGaA. (3/17/15). "Press Release: Merck Places U.S. Bond Amounting to US$ 4.0 Billion. Placement Is an Important Element of the Financing of the Proposed Acquisition of Sigma-Aldrich". Darmstadt. 2015-03-17
Novartis AG. (3/17/15). "Press Release: Novartis Receives EU Approval for Jakavi in Polycythemia Vera, First Targeted Therapy Approved for Patients with this Rare Blood Cancer". Basel. 2015-03-17
Lead Discovery Center GmbH. (3/17/15). "Press Release: Nature’s pharmacy – Plant-based Active Substance Kills Renal Cancer Cells. Collaboration with the LDC to Explore the Development of a Englerin-A Inspired Cancer Drug". Dortmund. 2015-03-17
Cartagenia N.V.. (3/17/15). "Press Release: Cartagenia Partners with N-of-One to Provide Pathology Laboratories and Cancer Centers Access to Clinical Interpretation Services". Boston, MA. 2015-03-17
Genedata AG. (3/17/15). "Press Release: Genedata Partners with Bayer Pharma AG on Innovative Workflow Platform for High-Throughput Cell Line Development". Basel. 2015-03-17
Kite Pharma, Inc.. (3/17/15). "Press Release: Kite Pharma Strengthens Its T Cell Receptor (TCR) Cancer Gene Therapy Platform Through Acquisition of T-Cell Factory B.V. (TCF)". Santa Monica, CA. 2015-03-17
Polyphor Ltd.. (3/17/15). "Press Release: Polyphor Appoints Michael Altorfer as New CEO and Strengthens Executive Management Team". Allschwil. 2015-03-17
Selvita S.A.. (3/16/15). "Press Release: Selvita Expands Its Proteomics Services Offer". Krakow. 2015-03-16
Qiagen N.V.. (3/16/15). "Press Release: Qiagen Expands Leadership in Liquid Biopsies with New Circulating Tumor Cell Technology for Development of Companion Diagnostics". Germantown, MD & Hilden. 2015-03-16
Roche. (3/16/15). "Press Release: Roche Launches Next-generation Duplex Test for Parvovirus B19 and Hepatitis A in Markets Accepting the CE Mark. cobas DPX Assay Increases Safety of Human Plasma and Plasma Products". Pleasanton, CA. 2015-03-16
Artes Biotechnology GmbH. (3/16/15). "Press Release: Artes Biotechnology and Boehringer Ingelheim Animal Health Announce Collaboration". Langenfeld. 2015-03-16
Lumora Ltd.. (3/16/15). "Press Release: Lumora’s Patented Sample Preparation Technologies in Commercial Use". Cambridgeshire. 2015-03-16
ADC Therapeutics S.a.r.l.. (3/16/15). "Press Release: ADC Therapeutics Submits Its First IND for a Novel Antibody Drug Conjugate against Lymphomas". Lausanne & London. 2015-03-16
next pagenext page 1 2 3 ... 42 43 44 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top